effect of alpha lipoic acid on cardiac autonomic function and platelet reactivity in type I diabetes

In patients with type I diabetes is alpha lipoic acid better than placebo for improvement of cardiac autonomic function and reduction of platelet reactivity?

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12610000291088

Acronym

AUTO-REACT trial

Enrollment

Registered

2010-04-12

Start date

2009-12-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The present randomized study will evaluate the effect of alpha lipoic acid compared to placebo on cardiac autonomic function and platelet reactivity in type I diabetic patients

Interventions

alpha lipoic acid dose: 800 mg once per day duration of administration: 4 weeks mode of administration: oral capsules

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

type I diabetes

Exclusion criteria

cardiac ischemia inflammatory diseases neoplastic and hematologic diseases

Outcome results